CIK 0000914475 · Large accelerated filer
NEUROCRINE BIOSCIENCES INC
Sign in to watch- Ticker
- NBIX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330525145
- Phone
- (858) 617-7600
- Business address
- 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,162,347
- in 4 filings, $3.2M under 10b5-1 plans
Net −$3,162,347. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-02 | Gano Kyle Chief Business Development Off | Option exercise · Non-Qualified Stock Option 10b5-1 | −68,884 | $19.59 | $1.3M | 0 |
| 2024-01-02 | Gano Kyle Chief Business Development Off | Option exercise · Incentive Stock Option 10b5-1 | −6,116 | $19.59 | $120K | 0 |
| 2024-01-02 | RASTETTER WILLIAM H Director | Option exercise 10b5-1 | +20,000 | $12.98 | $260K | 62,785 |
| 2024-01-02 | RASTETTER WILLIAM H Director | Sale 10b5-1 | −11,044 | $131.47 | $1.5M | 51,741 |
| 2024-01-02 | RASTETTER WILLIAM H Director | Option exercise · Non-Qualified Stock Option 10b5-1 | −20,000 | $12.98 | $260K | 0 |
| 2023-12-22 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −10,000 | $126.74 | $1.3M | 19,521 |
| 2023-12-22 | LYONS GARY A Director | Sale 10b5-1 | −10,000 | $130.04 | $1.3M | 193,697 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +14,000 | $81.05 | $1.1M | 31,263 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −14,000 | $129.99 | $1.8M | 17,263 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Option exercise 10b5-1 | +10,000 | $61.82 | $618K | 27,263 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Sale 10b5-1 | −10,000 | $126.79 | $1.3M | 17,263 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −14,000 | $81.05 | $1.1M | 8,129 |
| 2023-12-22 | Cooke Julie Chief Human Resources Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −10,000 | $61.82 | $618K | 23,532 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +6,978 | $81.05 | $566K | 36,499 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −6,978 | $120.30 | $839K | 29,521 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +6,947 | $81.05 | $563K | 36,468 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Sale 10b5-1 | −6,947 | $120.31 | $836K | 29,521 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −6,978 | $81.05 | $566K | 46,387 |
| 2023-12-12 | ROBERTS EIRY Chief Medical Officer | Option exercise · Non-Qualified Stock Option 10b5-1 | −6,947 | $81.05 | $563K | 39,440 |
| 2023-12-08 | ROBERTS EIRY Chief Medical Officer | Option exercise 10b5-1 | +200 | $81.05 | $16K | 29,721 |
Page 41 of 49 · 963 trades